anthranilic acid has been researched along with Atherosclerosis in 1 studies
anthranilic acid: RN given refers to parent cpd; structure in Negwer, 5th ed, #565
anthranilic acid : An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system.
Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Atherosclerosis is the major cause of cardiovascular disease (CVD), the leading cause of death worldwide." | 1.42 | Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development. ( Astola, N; Cole, JE; Cribbs, AP; Davies, AH; Feldmann, M; Goddard, ME; Green, P; Monaco, C; Park, I; Williams, RO, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cole, JE | 1 |
| Astola, N | 1 |
| Cribbs, AP | 1 |
| Goddard, ME | 1 |
| Park, I | 1 |
| Green, P | 1 |
| Davies, AH | 1 |
| Williams, RO | 1 |
| Feldmann, M | 1 |
| Monaco, C | 1 |
1 other study available for anthranilic acid and Atherosclerosis
| Article | Year |
|---|---|
Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cinnamates; Drug Design; Indoleamine-Pyrrole 2,3,-Dioxy | 2015 |